Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

Jeffrey M. Albert, Ana M. Gonzalez-Angulo, Merih Guray, Aysegul Sahin, Eric A. Strom, Welela Tereffe, Wendy A. Woodward, Susan L. Tucker, Kelly K. Hunt, Gabriel N. Hortobagyi, Thomas A. Buchholz

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy